Shares of Novo Nordisk A/S have been assigned a consensus rating of “Hold” from the seventeen brokerages that are presently covering the stock. Two equities research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company.